Main Article Content
Urinary Tract Infections (UTIs) are among the most common infections in both the out and inpatient settings. Increasing antimicrobial resistance of urinary pathogens has highlighted the need for reevaluation of the treatment options.1-3 Since management of UTIs widely varies, these guidelines may help physicians choose cost-effective options. 4-10
This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2. Naber KG, Schito G, Botto H, et al. Surveillance study in Europe and Brazil on Clinical aspect and antimicrobial resistance epidemiology in female with cystitis: implication for empiric therapy. Eur Urol 2008;54:1164-75.
3. Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American urinary tract infection collaborative alliance (NAUTICA). Int J Antimicrob Agents 2006;27:468-75.
4. Gupta K, Hooton TM, Naber KG, et al. International Clinical Practice Guideline: for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infections Disease Society of America and the European Society for microbiology and Infectious Disease. Clin Infect Dis 2011;52:103-20.
5. Worren JW, Absutyn E, Hebel JR, et al Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infections Diseases Society of American (IDSA). Clin Infect Dis 1999;59:745-58.
6. Stamm WE. Evaluating guidelines. Clin Infect Dis 2007;44:775-6.
7. Miller LG and Tang AW. Treatment of uncomplicated urinary infections in an era of increasing antimicrobial resistance. Mayo Clin Pro 2004;79:1048-53.
8. Czaja CA, Scholes D, Hooton TM, et al. Populationbased epidemiology analysis of acute pyelonephritis. Clin Infect Dis 2007;45:273-80.
9. Vellinga A, Cormican M, Harahoe B, et al. Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in Ireland. BMC Family Practice 2011;12:108-17.
10. Minardi D, Anzeo D, Conti A, et al. Urinary tract infections in women: etiology and treatment options. Inter national J of General Medicine 2011;4:333-43.
11. Villinga A, Cormican M, Hanahae B, et al. Predictive value of antimicrobial susceptibility from previous urinary tract infection in the treatment of re-infection. Br J Gen Pract 2010;60:511-3.
12. Hay AD. Managing UTI in primary case: should we be sending midstream urine sample. Br J Gen Pract 2010; 60:479-80.
13. Raz R. Postmenopausal women with recurrent UTI. Int J Antimicrob Agents 2001;17:269-71.
14. Kirjavainen PV, Pautler S, Baroja ML, et al. Abnormal immunological profile and vaginal microbial in women prone to urinary tract infections. Clin Vaccine Immunol 2009;16:29-36.
15. Patterson TF and Andriole VT. Detection, Significance, and therapy of bacteriuria in pregnancy. Update in management health care era. Infect Dis Clin North America 1997;11:359-608.
16. Hill JB, Sheffield JS, McIntiro DD, et al. Acute pyelo- nephritis in pregnancy. Obstel Gynecal 2005;105:18-23.
17. Geerling SE, Stolk RP, Camps MJ, et al. Risk factor for symptomatic urinary tract infection in women with diabetes. Diabetes Care 2000;23:1737-4.
18. Geerling SE, Stolk RP, Camps MJ, et al. Asymtomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus women Asyptomatic Bacteriuria Utrecht Study Gronp. Diabetes Care 2000; 23:744-9.
19. Ronald A. The etiology of urinary tract infection: tradi- tional and emerging pathogens. Dis Mon 2003;49:71-82.
20. Bevridge L, Davey PG, Phillips G, et al. Optimal management of urinary tract infections in order people. Clinical Intervention in Aging 2011;6:173-80.
21. Nicolle LE, Beadley S, Colgen R, et al. Infectious Disease Society of American Guideline for the Diagnosis and Treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643-54.
22. Zalmanovici TA, Green H, Paul M, et al. Antimicrobial agents for treating uncomplicated urinary tract infection in women. Cochrane Database Syst Rev 2010;10:CD007182.
23. Popovic M, Steinort D, Pillai S, et al. Fosfomycin: an old, new friend? Eur J Clin Microbiol Infect Dis 2010;29:127-42.
24. Fosformycin for urinary tract infections. Med Let Drugs Ther 1997;36:66-8.
25. HPA. Diagnosis of UTI. Quick reference guide for primary care 2009 at https://www.hpa.org.uk/web/ HPAwebFile/HPAweb.C/1194947330877. Accessed May 3, 2011.
26. Rubenstern JN and Schaefter Aj. Managing compli cated urinary tract infections: the urologic view. Infect Dis Clin North Am 2003;17:333-51.
27. Ramakrishnan K and Scheild DC. Diagnosis and man-agement of acute failure. Int J Antimicrob Agents 2008;31:40-5.
28. Nicolle LE. Short-term theory for urinary tract infection: success and failure. Int J Antimicrob Agents 2008;31:40-5.
29. ACOG Practice Bulletin No.91 Treatment of urinary tract infection in non pregnant women. Obslet Gynecol 2008;111:785-94.
30. European Association of Urology: guidelines or urological infection. Available at www.uroweb.org. Accessed 15-4-2011. This guideline outlines concisely and to-the-point the current recommendations for treatment of febrile UTI.
31. Bakke A and Digzanes A. Becteriuria in patients treated with clean, intermittent catherization. Scard J Infect Dis 1991;23:377-82.
32. Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc 1979;121:1193-254.
33. Wagenlehner FME, Schoniemann G, Hoyme C, et al. Epidermiology, diagnostic, therapy and management cited 2010 October I; Available from: www.unidussel-dorf.de/AWMF
34. Nicolle LE, Bradley S, Colgen R, et al. Infectious Disease Society of America guideline for diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643-54.
35. Waites KB, Canupp KC and Devivo MJ. Epi dermiology and risk factors for urinary tract infection following spinal cord injury. Arch Phys Med Rehabil 1993;74:691-5.